The Lithuanian office of Renalpharma Group has renewed its ISO 9001 and ISO 14001 certificates following a recertification audit conducted by Bureau Veritas in July. Both certificates will be valid for the next three years.

For Renalpharma Group, certification is not a formality. We supply products that patients depend on daily, and our partners need to know that every process behind them - from supplier qualification to storage conditions and delivery - is documented, controlled, and independently verified. Maintaining ISO 9001 and ISO 14001 is part of how we hold ourselves to that.

ISO 9001 sets international requirements for quality management, focusing on process consistency, traceability, and continual improvement. ISO 14001 addresses environmental management, including how an organisation identifies and reduces its environmental impact.

The Lithuanian office has held ISO 9001 and ISO 14001 certifications since 2023. Both systems will undergo annual surveillance audits during the new certification cycle.